TrialNetworks Customer Infinity Pharmaceuticals to Demonstrate Improved Patient Recruitment and Site Engagement Results at the SCOPE Summit for Clinical Ops Executives

• 

SCOPE provides a unique opportunity to engage leading clinical operations executives to better understand the evolving realities and challenges they face - and how TrialNetworks can help.

Needham, MA (PRWEB) January 23, 2014

TrialNetworks will have a major presence at this year’s SCOPE Summit for Clinical Ops Executives to be held in Miami, FL from February 4-6. In addition to showcasing the industry’s only Clinical Trial Optimization System to conference attendees, the company will lead and participate in educational sessions, unveil exciting new features of its technology platform, and co-host an engaging social networking event with other industry innovators.

On February 5 at 7:30am, TrialNetworks CEO Eric Silberstein and Infinity Pharmaceuticals Senior Project Manager Kathleen Hanlon will demonstrate results from a global Phase 2 oncology trial where the TrialNetworks platform was used to improve patient recruitment and site engagement among other areas of the study. The session is part of the Patient Recruitment and Global Site Selection tracks.

TrialNetworks will also officially launch Directory™, its clinical trial contact management app within its exclusive Clinical Trial Optimization System. Directory breaks new ground with a centralized and intuitive solution to improve collaboration efficiency between sponsors, sites, CROs and vendors throughout a trial. Preview the SCOPE announcement by reading the Applied Clinical Trials article about Directory.

The company will also co-host a welcome cocktail reception in Miami on February 3, the night before the conference begins along with BioPharm Clinical, PHT Corporation and Praxis.

Silberstein said, “So much of our system was developed due to our commitment and ability to uncover pain points, inefficiencies and workflow delays within the clinical research process – from listening carefully to our customers to shadowing study coordinators at global sites. We are looking forward to SCOPE because it will provide us a unique opportunity to engage leading clinical operations executives to better understand the evolving realities and challenges they face, and an ideal setting to share our vision and customer experiences regarding how our system can help.”

The TrialNetworks Clinical Trial Optimization System is a comprehensive cloud-based solution for key aspects of a clinical trial from startup through closeout – including feasibility surveys, training, trial conduct efficiency, patient recruitment and retention, site activation, document management and more.

To schedule a personalized demo of the company’s Clinical Trial Optimization System, visit TrialNetworks at SCOPE exhibit booth #58 or at http://www.trialnetworks.com.

About TrialNetworks
TrialNetworks, co-founded by U.S. Surgeon General nominee Dr. Vivek Murthy, provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using this modern and intuitive technology, customers such as Merck & Co., Biogen Idec and Infinity Pharmaceuticals are able to transform the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist™, Training™, Document Library™, Visit Guide™, Action Items™ and Directory™, are available in a unified and secure cloud-based interface. Customers ranging from biotechs to Top-10 pharma companies have implemented the TrialNetworks platform for use in Phase I-IV trials by more than 25,000 site staff in 60 countries. To learn why sponsors and CROs rely on TrialNetworks to optimize clinical trial operations, request a guided online demo at http://www.trialnetworks.com.

PDF Print